Unknown

Dataset Information

0

Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.


ABSTRACT: Polio eradication is progressing rapidly, and the live attenuated Sabin strains in the oral poliovirus vaccine (OPV) are being removed sequentially, starting with type 2 in April 2016. For risk mitigation, countries are introducing inactivated poliovirus vaccine (IPV) into routine vaccination programs. After April 2016, monovalent type 2 OPV will be available for type 2 outbreak control. Because the current IPV is not suitable for house-to-house vaccination campaigns (the intramuscular injections require health professionals), we developed a high-density microprojection array, the Nanopatch, delivered monovalent type 2 IPV (IPV2) vaccine to the skin. To assess the immunogenicity of the Nanopatch, we performed a dose-matched study in rats, comparing the immunogenicity of IPV2 delivered by intramuscular injection or Nanopatch immunisation. A single dose of 0.2 D-antigen units of IPV2 elicited protective levels of poliovirus antibodies in 100% of animals. However, animals receiving IPV2 by IM required at least 3 immunisations to reach the same neutralising antibody titres. This level of dose reduction (1/40th of a full dose) is unprecedented for poliovirus vaccine delivery. The ease of administration coupled with the dose reduction observed in this study points to the Nanopatch as a potential tool for facilitating inexpensive IPV for mass vaccination campaigns.

SUBMITTER: Muller DA 

PROVIDER: S-EPMC4766532 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5626768 | BioStudies
2020-01-01 | S-EPMC7240192 | BioStudies
2012-01-01 | S-EPMC3330118 | BioStudies
2017-01-01 | S-EPMC5324799 | BioStudies
2018-01-01 | S-EPMC5869272 | BioStudies
2012-01-01 | S-EPMC3426081 | BioStudies
1000-01-01 | S-EPMC4197908 | BioStudies
1000-01-01 | S-EPMC5388294 | BioStudies
2018-01-01 | S-EPMC6206113 | BioStudies
2018-01-01 | S-EPMC6206102 | BioStudies